Dr Jagannath on the Mechanism of Action of Linvoseltamab in R/R Multiple Myeloma

Sundar Jagannath, MBBS, discusses the mechanism of action and tolerability of linvoseltamab in patients with relapsed/refractory multiple myeloma.

Related Keywords

Sundar Jagannath ,Tisch Cancer Institute ,Multiple Myeloma ,Mount Sinai ,